Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05309603 · ClinicalTrials.gov registry record · NA

Alterations in Gait, Strength, and Power After Ruck Marching

A NA study of Fatigue and Exercise, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT05309603 is a NA study of Fatigue and Exercise that has completed, run by State University of New York at Buffalo. The registered enrollment target is 26 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05309603, a NA study of Fatigue and Exercise, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

Conditions Studied

Interventions

  • OTHER Walking
  • OTHER Loaded Walking High
  • OTHER Loaded Walking Mid

Study Locations (1)

New York

  • University at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2022-03-21
Est. Completion 2023-07-21
Phase NA

What the Registry Record Tells You About NCT05309603

The ClinicalTrials.gov registry entry for NCT05309603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (88% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 3 interventions - of which Walking is the first listed.

NCT05309603 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05309603 about?

NCT05309603 is a clinical study titled "Alterations in Gait, Strength, and Power After Ruck Marching". The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

What is the current status of trial NCT05309603?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-03-21. Estimated completion is 2023-07-21.

What conditions does trial NCT05309603 study?

This clinical trial studies the following conditions: Fatigue, Exercise.

What interventions are being tested in trial NCT05309603?

The interventions under investigation include: Walking (OTHER), Loaded Walking High (OTHER), Loaded Walking Mid (OTHER).

Who is sponsoring clinical trial NCT05309603?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05309603 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatigue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.